Find clinical trials for Asthma in Hanyang, Seoul
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Asthma trials near Hanyang, Seoul, KOR:
in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...
Phase 3
Seoul, South Korea and 43 other locations
The objective of this study is to assess the potential for GB-0895 treatment to improve the health of adolescents and adults with severe asthma...
Phase 3
Seoul, Seoul, South Korea and 109 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Seoul, South Korea and 335 other locations
Asthma is a chronic condition marked by narrowed and swollen airways due to inflammation leading to recurring symptoms that can vary and wor...
Phase 3
Seoul, South Korea and 49 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
Seoul, South Korea and 146 other locations
The primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT st...
Phase 2
Seoul, South Korea, South Korea and 101 other locations
This is a study of amlitelimab for the treatment of participants with moderate-to-severe asthma. The study will have a double-blind treatmen...
Phase 2
Seoul, Seoul-teukbyeolsi, South Korea and 69 other locations
PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, ...
Phase 2
Seoul, Seoul-teukbyeolsi [seoul], South Korea and 136 other locations
trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma...
Phase 4
Seoul, South Korea and 116 other locations
This Phase 2b study is designed to evaluate the safety and efficacy of KT-621 in participants with uncontrolled moderate to severe eosinophilic asthma...
Phase 2
Seoul, South Korea and 70 other locations
Clinical trials
Research sites
Resources
Legal